AI-based antibody discovery platform identifies novel, diverse and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strains
C. Moldovan Loomis, T. Lahlali, D. Van Citters, M. Sprague, G. Neveu, L. Somody, C. C. Siska, D. Deming, A. J. Asakawa, T. Amimeur, J. M. Shaver, C. Carbonelle, R. R. Ketchem, A. Alam, R. H. Clark
This paper presents an AI-based platform for rapid antibody discovery against SARS-CoV-2, identifying novel therapeutic antibodies effective against multiple strains.
bioRxiv · Aug 21, 2023 · PreprintImmunology